Literature DB >> 2432813

Natural course of bleomycin-induced pneumonitis. A follow-up study.

P W Van Barneveld, D T Sleijfer, T W van der Mark, N H Mulder, H S Koops, H J Sluiter, R Peset.   

Abstract

In this study, long-term pulmonary complications of bleomycin were evaluated in 8 patients with bleomycin-induced pneumonitis (BIP). The lung function parameters: VC, alveolar volume, transfer factor for carbon monoxide of the lungs, diffusing capacity of the alveolocapillary membrane, and pulmonary capillary blood volume were studied in all patients for as long as 2 yr after the development of BIP. Perfusion scans with 133Xe and 99mTc were performed in these patients 2 yr after BIP developed. We concluded that if a patient survives the acute event of BIP, the pulmonary symptoms and the changes in these lung function parameters are completely reversible.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2432813     DOI: 10.1164/arrd.1987.135.1.48

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  5 in total

1.  TGF-beta is a critical mediator of acute lung injury.

Authors:  J F Pittet; M J Griffiths; T Geiser; N Kaminski; S L Dalton; X Huang; L A Brown; P J Gotwals; V E Koteliansky; M A Matthay; D Sheppard
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

2.  Cause-Specific Mortality Following Initial Chemotherapy in a Population-Based Cohort of Patients With Classical Hodgkin Lymphoma, 2000-2016.

Authors:  Graça M Dores; Rochelle E Curtis; Nicole H Dalal; Martha S Linet; Lindsay M Morton
Journal:  J Clin Oncol       Date:  2020-09-18       Impact factor: 44.544

3.  The role of the receptor for advanced glycation end-products in a murine model of silicosis.

Authors:  Lasse Ramsgaard; Judson M Englert; Jacob Tobolewski; Lauren Tomai; Cheryl L Fattman; Adriana S Leme; A Murat Kaynar; Steven D Shapiro; Jan J Enghild; Tim D Oury
Journal:  PLoS One       Date:  2010-03-19       Impact factor: 3.240

4.  Long-term follow-up of pulmonary function in patients cured from testicular cancer with combination chemotherapy including bleomycin.

Authors:  G Lehne; B Johansen; S D Fosså
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640

5.  Decrease in pulmonary function during bleomycin-containing combination chemotherapy for testicular cancer: not only a bleomycin effect.

Authors:  S Sleijfer; T W van der Mark; H Schraffordt Koops; N H Mulder
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.